Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gallbladder neoplasia is associated with a higher incidence of cholangiocarcinoma in patients with primary sclerosing cholangitis.

Canadian liver journal·2026
Same author

A call for action: The need to quantify the "-itis" in primary sclerosing cholangitis.

Journal of hepatology·2026
Same author

Oral Vancomycin Is an Effective Therapy in Adult Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.

Gastro hep advances·2026
Same author

Compositional and functional differences of gut microbiome and metabolome inform pathogenesis of cholestatic liver disease.

Gut microbes·2026
Same author

Failure-to-rescue as a determinant of overall survival following resection for perihilar cholangiocarcinoma.

JHEP reports : innovation in hepatology·2025
Same author

Reply: From risk alert to decision support: Enhancing the clinical value of the AI model for cholangiocarcinoma.

Hepatology (Baltimore, Md.)·2025
Same journal

Opportunities and Risks of Host-targeting Antiviral Strategies for Hepatitis C.

Current hepatitis reports·2020
Same journal

Managing Hepatitis C in Users of Illicit Drugs.

Current hepatitis reports·2013
Same journal

Alcoholic Hepatitis: Steroids vs. Pentoxifylline.

Current hepatitis reports·2013
Same journal

DILI: New Insights into Diagnosis and Management.

Current hepatitis reports·2013
Same journal

Optimal Management of the Hepatitis B Patient Who Desires Pregnancy or Is Pregnant.

Current hepatitis reports·2012
Same journal

New and Evolving Management Paradigms for Hepatitis C after Liver Transplantation.

Current hepatitis reports·2012
See all related articles

Related Experiment Video

Updated: May 11, 2026

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis
04:38

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis

Published on: March 28, 2018

Primary Sclerosing Cholangitis: Current and Future Management Strategies.

John E Eaton1, Jayant A Talwalkar

  • 1Cholestatic Liver Diseases Study Group, Department of Gastroenterology and Hepatology, Mayo Clinic College of Medicine.

Current Hepatitis Reports
|May 18, 2013
PubMed
Summary
This summary is machine-generated.

Primary sclerosing cholangitis (PSC) is a chronic liver disease with unknown causes and no cures. This review covers PSC

Keywords:
DiagnosisManagementPrimary sclerosing cholangitis

Related Experiment Videos

Last Updated: May 11, 2026

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis
04:38

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis

Published on: March 28, 2018

Area of Science:

  • Hepatology
  • Gastroenterology
  • Autoimmune Diseases

Background:

  • Primary sclerosing cholangitis (PSC) is a rare, chronic cholestatic liver disease of unknown etiology.
  • It is frequently associated with inflammatory bowel disease (IBD).
  • PSC significantly increases the risk of developing hepatobiliary and colorectal cancers.

Purpose of the Study:

  • To review the clinical presentation and diagnostic methods for PSC.
  • To discuss comorbidities associated with PSC.
  • To outline screening protocols for PSC-related malignancies and explore current and future therapeutic strategies.

Main Methods:

  • Literature review of clinical features, diagnostics, and management of PSC.
  • Analysis of screening strategies for associated malignancies.
  • Evaluation of existing and emerging treatment options.

Main Results:

  • PSC diagnosis relies on clinical, biochemical, and imaging findings.
  • Associated conditions include IBD, pancreatitis, and osteoporosis.
  • Surveillance for cholangiocarcinoma and colorectal cancer is crucial.

Conclusions:

  • PSC management requires a multidisciplinary approach.
  • Early diagnosis and vigilant screening are key to improving outcomes.
  • Ongoing research aims to identify effective therapies for PSC.